UCB launches Eu2bn refi facility
Belgian biopharma group UCB has launched a Eu2bn loan to refinance part of the debt it took on to buy German rival Schwarz Pharma in 2006.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
